IDEX Corporation — Q1 2021 Form 10-Q
Business context and period: Unaudited results for the three months ended March 31, 2021, compared with Q1 2020. IDEX designs and manufactures products across Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP).
Financial performance
- Revenue: $652.0 million, up 10% year over year; organic sales increased 6%, acquisitions contributed 1%, and foreign currency translation contributed 3%.
- Profit and margins: Gross profit was $292.6 million, up 8%; gross margin was 44.9%, down 0.8 percentage points. Operating income was $155.5 million, up 11%, and operating margin was 23.9%, up 0.4 points. Net income attributable to IDEX was $112.7 million, up 10%. Diluted EPS was $1.48 versus $1.33.
- Adjusted/non-GAAP measures: Adjusted operating income was $158.4 million, adjusted net income $114.9 million, adjusted diluted EPS $1.51, and adjusted EBITDA $180.8 million (27.7% margin). These exclude specified restructuring, impairment, and inventory step-up items; company definitions may differ from other issuers’ measures.
- Segment results: FMT sales rose 7% to $243.4 million, while operating margin fell to 25.8% from 29.4%. HST sales rose 12% to $250.4 million and margin improved to 26.6% from 23.5%. FSDP sales rose 11% to $159.5 million and margin improved to 27.9% from 26.4%.
- Cash flow: Operating cash flow was $109.3 million versus $84.8 million. Capital expenditures were $14.6 million, producing free cash flow of $94.7 million versus $72.0 million. Cash declined $67.7 million during the quarter to $958.1 million, including the effects of acquisitions, dividends, and currency translation.
- Liquidity and debt: Current assets were $1.65 billion and current liabilities $377.5 million; reported working capital was $1.27 billion and the current ratio 4.4:1. Borrowings totaled approximately $1.05 billion, primarily fixed-rate notes; cash exceeded borrowings by about $92 million. The $800 million revolver had no borrowings and $792.9 million available after letters of credit. The company reported compliance with debt covenants.
Material changes and notable items
- Growth was broad across HST and FSDP; FMT also grew, but its operating income and margin declined, partly due to inventory reserves, lower acquired-business margins, restructuring, and ABEL’s inventory step-up.
- Q1 2021 included $2.2 million of restructuring and asset impairment charges and a $0.7 million fair-value inventory step-up charge related to ABEL. Restructuring actions included employee reductions and facility consolidation.
- IDEX acquired ABEL Pumps on March 10 for $106.2 million in cash, funded from cash on hand. Preliminary purchase accounting included $59.0 million of goodwill and $46.0 million of intangible assets.
- IDEX sold CiDRA Precision Services on March 12 for $1.0 million, recording a $0.5 million pretax gain; the business contributed $0.9 million of revenue before the sale.
- Foreign currency translation reduced other comprehensive income by $48.4 million. The effective tax rate rose to 22.6% from 20.0%, primarily due to lower excess tax benefits from share-based compensation.
- After quarter-end, on April 27, IDEX agreed to acquire Airtech for $470 million in cash, subject to customary adjustments, and expected to close by the end of Q2 2021.
Outlook, risks, and contingencies
Management said end markets improved from the second half of 2020 through Q1 2021 and expected them to continue normalizing toward historical levels during 2021. The filing provides no specific full-year revenue or earnings guidance. Management stated that cash, operating cash flow, and available revolver capacity were expected to fund operations and obligations for at least the next 12 months, while cautioning that COVID-19 effects remain uncertain.
Risks include pandemic-related disruptions to operations, customers and supply chains; industrial activity, demand and pricing; acquisition integration and financing; foreign exchange, tariffs, interest rates, labor and material costs; and litigation and other contingencies. The company reported ordinary-course legal matters and asbestos-related lawsuits; it did not believe these would have a material adverse effect, while noting uncertainty about future insurance coverage. A $350 million 4.2% note maturity falls in December 2021; the company said it had the ability and intent to refinance or repay it using revolver capacity. Disclosure controls were judged effective, with no material quarterly change in internal control over financial reporting.
Important facts for investors to verify
- Whether organic growth and end-market recovery continue, particularly given the weaker FMT margin and COVID-related uncertainty.
- Whether working-capital movements, cash conversion, and the cash balance remain supportive as acquisition spending and dividends continue.
- How the Airtech acquisition is financed and integrated, and whether it delivers expected strategic and financial benefits.
- How the December 2021 note maturity is addressed and whether covenant compliance and borrowing capacity are maintained.
- Whether acquisition-related costs, inventory reserves, restructuring charges, and non-GAAP adjustments recur or materially affect reported margins.